SCHEMBL7984374

SCHEMBL7984374

CCc1nc2ncn(Cc3cc(C)cc(C)c3)c2c(=O)[nH]1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KMT2A Q03164 1/20 0.42
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
BRD4 O60885 2/20 0.35
ADORA1 P30542 1/20 0.35
TP53 P04637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TPH1 P17752 1/20 0.34
TPH2 Q8IWU9 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
BRD2 P25440 1/20 0.34
BRD3 Q15059 1/20 0.34
BRDT Q58F21 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974255 0.89 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7987432 0.89 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7987957 0.88 HPGD (0.43) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7975251 0.85 SMN1; SMN2 (0.60) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7985241 0.83 HSP90AA1 (0.45) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7985527 0.83 HPGD (0.41) HPGDALDH1A1SMN1; SMN2KMT2ATP53
SCHEMBL7984524 0.82 HPGD (0.52) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B2
SCHEMBL7988126 0.82 HPGD (0.49) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7985648 0.82 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7974269 0.82 TNF (0.44) HPGDALDH1A1SMN1; SMN2KMT2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed